Stem Cells
USC researchers begin early trial of dopamine-producing stem cell implants for Parkinson’s
An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya
Keck Medicine of USC researchers are testing an experimental approach to Parkinson’s disease that implants lab-grown, dopamine-producing cells into a movement-control region of the brain. The early-stage Phase 1 REPLACE trial involves up to 12 people with moderate to moderate-severe Parkinson’s disease, and the U.S. Food and Drug Administration has granted the study fast-track designation.
An experimental therapy using stem cells from young donors has shown promise in improving mobility for frail older people. In a trial involving 148 participants, infusions of laromestrocel led to significant gains in walking distance. Researchers highlight its potential to address biological roots of frailty.
An Ruwaito ta hanyar AI An Binciki Gaskiya
Doctors at Keck Medicine of USC are implanting lab-grown, dopamine-producing cells into the brains of people with Parkinson’s disease in an early-stage clinical trial that will enroll up to 12 participants across three U.S. sites.
A Stanford Medicine team reports that a single dose of the anti‑CD117 antibody briquilimab allowed three children with Fanconi anemia to undergo stem cell transplants without radiation or busulfan, achieving near‑complete donor cell engraftment in a phase 1b study published in Nature Medicine.
An Ruwaito ta hanyar AI An Binciki Gaskiya
Rockefeller University scientists report that, in mice, hair follicle stem cells switch from fueling hair growth to repairing wounds when the amino acid serine is scarce — a shift governed by the integrated stress response. The peer‑reviewed findings in Cell Metabolism suggest dietary or drug strategies could eventually help speed wound healing.
Researchers at MIT have discovered that the amino acid cysteine can enhance the small intestine's ability to heal itself. In experiments with mice, a cysteine-rich diet activated immune cells to promote tissue regeneration after damage from radiation or chemotherapy. The findings, published in Nature, suggest potential dietary strategies to mitigate treatment side effects.
An Ruwaito ta hanyar AI
Researchers at Stanford University have developed a method to grow thousands of identical brain organoids using xanthan gum, a common food additive, to prevent them from sticking together. This breakthrough, led by Sergiu Pasca and Sarah Heilshorn, enables large-scale testing for brain development and drug screening. The technique could advance studies on disorders like autism and schizophrenia.
UBC researchers show how to reliably generate helper T cells from stem cells by tuning Notch signaling
January 09, 2026 04:42USC launches trial for tiny stem cell eye implant
January 07, 2026 17:44Japanese scientists recreate human brain circuits in lab
December 15, 2025 20:22Stem cell ‘pain sponge’ therapy shows promise for osteoarthritis relief and joint protection
November 27, 2025 18:15Nanoflowers supercharge stem cells to recharge aging tissues
October 30, 2025 08:22Electrical stimulation reprograms human immune cells to spur repair
October 30, 2025 01:00Flatworm stem cells respond to distant cues, study finds
October 29, 2025 15:18Stem cell therapy lowers heart failure risk after heart attack
October 25, 2025 04:04Study links graying hair and melanoma to stress responses in pigment stem cells
October 23, 2025 11:03Scientists reverse brain aging in mice using stem cells